Australia markets closed

Retractable Technologies, Inc. (RVP)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
1.20000.0000 (0.00%)
At close: 04:00PM EDT
1.2001 +0.00 (+0.01%)
After hours: 06:26PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close1.2000
Open1.2000
Bid1.0800 x 900
Ask1.3000 x 1000
Day's range1.2000 - 1.2199
52-week range0.9500 - 1.9000
Volume26,326
Avg. volume74,620
Market cap35.925M
Beta (5Y monthly)2.12
PE ratio (TTM)N/A
EPS (TTM)-0.3700
Earnings date28 Mar 2024 - 01 Apr 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Insider Monkey

    15 Cash-Rich Penny Stocks Hedge Funds Are Buying

    In this article, we will take a detailed look at the 15 Cash-Rich Penny Stocks Hedge Funds Are Buying. For a quick overview of such stocks, read our article 5 Cash-Rich Penny Stocks Hedge Funds Are Buying. Risky asset classes got punished after the Federal Reserve started to raise interest rates to tackle inflation. But amid the talk of […]

  • Business Wire

    Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders

    LITTLE ELM, Texas, December 29, 2023--Retractable Technologies, Inc. ("Retractable") (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning October 1, 2023 through December 31, 2023. The dividends will be paid on January 22, 20

  • Business Wire

    Retractable Technologies, Inc. Not Impacted by FDA Safety Communication

    LITTLE ELM, Texas, December 01, 2023--Retractable Technologies, Inc. (NYSE American: RVP) reports that the FDA Safety Communication "Evaluating Plastic Syringes Made in China for Potential Device Failures" on November 30, 2023 does not refer to syringes from Retractable Technologies Inc. The FDA identified quality issues related to "leaks, breakage, and other problems after manufacturers made changes to the syringe dimensions." Retractable Technologies has not incorporated any recent changes to